Mckesson recalls 150 mg/mL Medroxyprogesterone Acetate injectable vials shipped from India in April 2025 due to storage delays. Products may have been improperly stored, risking safety and quality. Check NDC 55150-0330-01 and lot 1MP24042.
Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.
Mckesson is recalling specific Medroxyprogesterone Acetate injectable vials shipped from India in April 2025. These products may have been stored incorrectly due to shipping delays, potentially affecting safety and quality. This recall affects healthcare providers using these vials for medical treatments.
Severe thunderstorms caused shipping delays for products shipped on April 2, 2025. These products were delivered after the 48-hour recommended storage window, potentially leading to improper storage conditions. This could affect the product's safety, quality, identity, potency, and purity.
Healthcare providers who received the recalled vials from the shipment dated April 2, 2025. Patients receiving these vials under medical supervision are at minimal risk if the vials were stored properly.
Check for NDC code 55150-0330-01 and lot number 1MP24042 on the vial. The vials were manufactured in India and shipped for use in the U.S. by Eugia US LLC.
Look for NDC 55150-0330-01 and lot number 1MP24042 on the vial label.
The recall was initiated because severe thunderstorms caused shipping delays for products shipped on April 2, 2025, leading to potential improper storage conditions that could affect product safety and quality.
The official recall notice does not specify a remedy or action for affected products. Check the vial label for NDC 55150-0330-01 and lot number 1MP24042 to confirm if it is affected.
The recall indicates potential risks due to improper storage, but the official notice does not specify that the product is unsafe. Healthcare providers should follow standard storage guidelines.
We’ve drafted a message you can send Mckesson Medical-Surgical to request your refund or repair — edit it as you like.
Subject: Recall D-0400-2025 — Mckesson Medical-Surgical Mckesson Medical-Surgical Hello, I own a Mckesson Medical-Surgical that is covered by recall D-0400-2025 from Mckesson Medical-Surgical. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
